High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: a cross-sectional study

To characterize treatment patterns for patients with psoriatic arthritis (PsA) currently receiving any disease-modifying antirheumatic drug (DMARD).The Strategy for Psoriatic Arthritis In Germany (SPAIG) study was a retrospective observational study conducted from May to November 2017 at 46 rheumato...

Full description

Saved in:
Bibliographic Details
Main Authors: Behrens, Frank (Author) , Rech, Jürgen (Author) , Thaçi, Diamant (Author) , Zinke, Silke (Author) , Rothnie, Kieran J. (Author) , Oefner Daamen, Carolin (Author) , Leipe, Jan (Author)
Format: Article (Journal)
Language:English
Published: January 2022
In: Modern rheumatology
Year: 2022, Volume: 32, Issue: 1, Pages: 87-95
ISSN:1439-7609
DOI:10.1080/14397595.2020.1816597
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/14397595.2020.1816597
Get full text
Author Notes:Frank Behrens, Jürgen Rech, Diamant Thaçi, Silke Zinke, Kieran J Rothnie, Carolin (Oefner) Daamen, Jan Leipe

MARC

LEADER 00000caa a2200000 c 4500
001 1824533772
003 DE-627
005 20230426081041.0
007 cr uuu---uuuuu
008 221206s2022 xx |||||o 00| ||eng c
024 7 |a 10.1080/14397595.2020.1816597  |2 doi 
035 |a (DE-627)1824533772 
035 |a (DE-599)KXP1824533772 
035 |a (OCoLC)1361670070 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Behrens, Frank  |d 1970-  |e VerfasserIn  |0 (DE-588)128766719  |0 (DE-627)379138840  |0 (DE-576)297322435  |4 aut 
245 1 0 |a High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs  |b a cross-sectional study  |c Frank Behrens, Jürgen Rech, Diamant Thaçi, Silke Zinke, Kieran J Rothnie, Carolin (Oefner) Daamen, Jan Leipe 
264 1 |c January 2022 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 06.12.2022 
520 |a To characterize treatment patterns for patients with psoriatic arthritis (PsA) currently receiving any disease-modifying antirheumatic drug (DMARD).The Strategy for Psoriatic Arthritis In Germany (SPAIG) study was a retrospective observational study conducted from May to November 2017 at 46 rheumatology centers. Current and previous treatment data were collected at a single visit from adult patients with PsA and psoriasis who received DMARD treatment for ≥6 of the previous 12 months. The primary outcome was the proportion of patients receiving a biologic DMARD (bDMARD). Multinomial logistic regression analysis was used to evaluate associations between current characteristics and initial choice of therapy.Mean age of the 316 patients was 55.1 years and mean PsA disease duration was 9.9 years. PsA activity was generally comparable across treatment groups. In this cohort, 57.3% of patients were currently treated with bDMARDs, 37.7% with conventional synthetic DMARDs, and 4.4% with targeted synthetic DMARDs. Almost half (48.4%) of patients reported DMARD modifications in the previous 12 months. Specific comorbidities and patient/disease characteristics were associated with initial therapy.DMARD treatment of PsA is frequently modified, suggesting the need for more effective therapies and assessment tools. 
700 1 |a Rech, Jürgen  |e VerfasserIn  |0 (DE-588)121212667X  |0 (DE-627)1700736612  |4 aut 
700 1 |a Thaçi, Diamant  |e VerfasserIn  |4 aut 
700 1 |a Zinke, Silke  |d 1968-  |e VerfasserIn  |0 (DE-588)120400588  |0 (DE-627)696637561  |0 (DE-576)292199481  |4 aut 
700 1 |a Rothnie, Kieran J.  |e VerfasserIn  |4 aut 
700 1 |a Oefner Daamen, Carolin  |e VerfasserIn  |4 aut 
700 1 |a Leipe, Jan  |d 1976-  |e VerfasserIn  |0 (DE-588)131797824  |0 (DE-627)51426280X  |0 (DE-576)298758563  |4 aut 
773 0 8 |i Enthalten in  |t Modern rheumatology  |d Oxford : Oxford University Press, 2000  |g 32(2022), 1 vom: Jan., Seite 87-95  |h Online-Ressource  |w (DE-627)320627497  |w (DE-600)2023498-3  |w (DE-576)113948662  |x 1439-7609  |7 nnas  |a High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs a cross-sectional study 
773 1 8 |g volume:32  |g year:2022  |g number:1  |g month:01  |g pages:87-95  |g extent:9  |a High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs a cross-sectional study 
856 4 0 |u https://doi.org/10.1080/14397595.2020.1816597  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221206 
993 |a Article 
994 |a 2022 
998 |g 131797824  |a Leipe, Jan  |m 131797824:Leipe, Jan  |d 60000  |d 61400  |e 60000PL131797824  |e 61400PL131797824  |k 0/60000/  |k 1/60000/61400/  |p 7  |y j 
999 |a KXP-PPN1824533772  |e 4225518582 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 06.12.2022"],"name":{"displayForm":["Frank Behrens, Jürgen Rech, Diamant Thaçi, Silke Zinke, Kieran J Rothnie, Carolin (Oefner) Daamen, Jan Leipe"]},"person":[{"roleDisplay":"VerfasserIn","display":"Behrens, Frank","role":"aut","family":"Behrens","given":"Frank"},{"roleDisplay":"VerfasserIn","display":"Rech, Jürgen","role":"aut","given":"Jürgen","family":"Rech"},{"roleDisplay":"VerfasserIn","display":"Thaçi, Diamant","role":"aut","family":"Thaçi","given":"Diamant"},{"roleDisplay":"VerfasserIn","display":"Zinke, Silke","role":"aut","family":"Zinke","given":"Silke"},{"family":"Rothnie","given":"Kieran J.","display":"Rothnie, Kieran J.","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Oefner Daamen","given":"Carolin","roleDisplay":"VerfasserIn","role":"aut","display":"Oefner Daamen, Carolin"},{"given":"Jan","family":"Leipe","display":"Leipe, Jan","role":"aut","roleDisplay":"VerfasserIn"}],"id":{"eki":["1824533772"],"doi":["10.1080/14397595.2020.1816597"]},"recId":"1824533772","type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs","title_sort":"High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs","subtitle":"a cross-sectional study"}],"relHost":[{"name":{"displayForm":["the Japan Rheumatism Association"]},"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["10.2000 -"],"note":["Gesehen am 12.09.2022","Fortsetzung der Druck-Ausgabe"],"id":{"eki":["320627497"],"issn":["1439-7609"],"zdb":["2023498-3"]},"recId":"320627497","type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"1","year":"2022","extent":"9","pages":"87-95","volume":"32","text":"32(2022), 1 vom: Jan., Seite 87-95"},"disp":"High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs a cross-sectional studyModern rheumatology","language":["eng"],"title":[{"title_sort":"Modern rheumatology","title":"Modern rheumatology"}],"origin":[{"dateIssuedDisp":"2000-","publisherPlace":"Oxford ; Tokyo ; Abingdon","dateIssuedKey":"2000","publisher":"Oxford University Press ; Springer ; Taylor & Francis Group"}]}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"January 2022"}],"language":["eng"]} 
SRT |a BEHRENSFRAHIGHRATESO2022